X

Trial Profile

Comparative bioavailability study of T-4288 tablet and T-4288 capsule in healthy adult subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 12 Oct 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Solithromycin (Primary)
Indications Anthrax; Bacterial infections; Chlamydial infections; Chronic obstructive pulmonary disease; Community-acquired pneumonia; Cystic fibrosis; Enterococcal infections; Gonorrhoea; Legionella infections; Mycoplasma infections; Non-alcoholic steatohepatitis; Obstetric and gynaecological infections; Otitis media; Otorhinolaryngological infections
Focus Pharmacokinetics
Sponsors Toyama Chemical

Most Recent Events

11 Jan 2017 Status changed from recruiting to completed.
08 Jun 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com